by Mila McManus, MD
It appears that not only does semaglutide help millions of people lose weight, but it is also having a favorable impact on cardiovascular health. According to the New England Journal of Medicine, the reduced risk for heart failure appears to be a result of upstream metabolic drivers.
In one trial, people with heart failure who received weekly injections of semaglutide for 52 weeks experienced substantial improvements in symptoms and physical function than those who received a placebo. This trial involved 529 participants with obesity. In a larger trial by Novo Nordisk, involving 17,604 adults with cardiovascular disease who were also overweight or obese, semaglutide reduced major adverse cardiovascular events by 20%.
To learn more about semaglutide and our Weight Loss Program, contact us at 281-298-6742.
Semaglutide Improves Heart Failure and Cardiovascular Disease. Medical News in Brief: Journal of the American Medical Association. September 6, 2023.